OTCMDOSEF
Market cap5mUSD
Dec 03, Last price
0.14USD
Name
Lucy Scientific Discovery Inc
Chart & Performance
P/E
—
P/S
193.28
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
43k
+168.49%
Net income
-2m
L-8.14%
CFO
-481k
L-71.89%
Profile
Doseology Sciences Inc. engages in the cultivation and extraction of nutraceutical and pharmaceutical products in Canada. It focuses on research, development, and sale of medicinal mushroom products, including tinctures and powders. The company sells its products online through doseology.com. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY |
|---|---|---|---|
| 2023‑06 | 2022‑06 | 2021‑06 | |
| Income | |||
Revenues | 43 168.49% | 16 | |
Cost of revenue | 762 | 1,693 | |
Unusual Expense (Income) | |||
NOPBT | (719) | (1,677) | |
NOPBT Margin | |||
Operating Taxes | 36 | 76 | |
Tax Rate | |||
NOPAT | (755) | (1,753) | |
Net income | (1,782) -8.14% | (1,939) 19.23% | |
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | (35) | ||
BB yield | |||
| Debt | |||
Debt current | 43 | 93 | |
Long-term debt | 58 | 1,399 | |
Deferred revenue | |||
Other long-term liabilities | |||
Net debt | (1,201) | (382) | |
| Cash flow | |||
Cash from operating activities | (481) | (1,711) | |
CAPEX | (8) | ||
Cash from investing activities | (8) | ||
Cash from financing activities | (140) | (140) | |
FCF | 1,044 | (2,701) | |
| Balance | |||
Cash | 1,301 | 1,874 | |
Long term investments | |||
Excess cash | 1,299 | 1,874 | |
Stockholders' equity | 1,300 | 2,998 | |
Invested Capital | 51 | 1,870 | |
ROIC | |||
ROCE | |||
| EV | |||
Common stock shares outstanding | 41,100 | 39,097 | |
Price | |||
Market cap | |||
EV | |||
EBITDA | (653) | (1,538) | |
EV/EBITDA | |||
Interest | 36 | 76 | |
Interest/NOPBT | |||